Cognitive Enhancement In Psychiatric Disorders

Disturbances of various domains of cognitive function have been shown to provide a major determinant of outcome for patients with psychiatric conditions. Cognitive impairment is present in an array of diseases, including schizophrenia (with its prodromal stage), mood disorder, autism spectrum disorder, obsessive-compulsive disorder, anxiety disorder, post-traumatic disorder, and eating disorder. In an effort to develop effective therapeutics for cognitive impairment, bridging of preclinical and clinical evidence has been attempted. This edited Book will provide a forum for researchers and clinicians interested in the phenomenology, underlying mechanisms, and treatment of cognitive impairment associated with psychiatric illnesses. Twenty-eight contributions from 8 countries in Europe, Middle East, Asia, North America, and South America represent studies dealing with genetic, molecular, imaging, physiological, psychological, and behavioral issues. Information in this Book will facilitate the development of therapeutics of greater clinical value.

A practical guide on how to assess and treat schizophrenia and related disorders using cognitive rehabilitation.

This text compiles a series of educational and thought-provoking chapters from the world's leading cognitive and clinical scientists to describe the latest research on cognitive impairments in a host of pathological conditions that affect CNS functioning, the available treatments for these impairments, and how new treatments are being tested. This volume advances the field toward the availability of cognitive enhancing drugs and devices that will benefit those who need them most and others who may believe that these techniques can help them to thrive

This edited volume bridges the gap between basic and applied science in understanding the nature and treatment of psychiatric disorders and mental health problems. Topics such as brain imaging, physiological indices of emotion, cognitive enhancement strategies, neuropsychological and cognitive training, and related techniques as tools for increasing our understanding of anxiety, depression, addictions, schizophrenia, ADHD, and other disorders are emphasized. Mental health professionals will learn how to integrate a neurocognitive perspective into their clinical research and practice of psychotherapy.

This volume covers the dramatic developments that have occurred in basic neuroscience and clinical research in cognitive neurology and dementia. It is based on the clinical approach to the patient, and provides essential knowledge that is fundamental to clinical practice.

Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors addresses the gap that exists in research on the topic, gathering multidisciplinary knowledge and tools that help the reader understand the basics of cognitive enhancement. It also provides assistance in designing procedures and pharmacological approaches to further the use of novel cognitive enhancers, a field that offers potential benefit to a variety of populations, including those with neurologic and psychiatric disorders, mild aging-related cognitive impairment, and those who want to improve intellectual performance. The text builds on our knowledge of the molecular/cellular basis of cognitive function, offering the technological developments that may soon enhance cognition. Separate sections cover enhancement drugs, environmental conditions, and genetic factors in terms of both human and animal studies, including both healthy/young and aging/diseased individuals. Provides a multidisciplinary knowledge, enabling a further understanding of cognitive enhancement Offers coverage of the pharmacologic, environmental, and genetic factors relevant to the topic Discusses cognitive enhancement from the perspective of both healthy and diseased or aging populations Topics are discussed in terms of both human and animal studies

There has been much recent excitement amongst neuroscientists and ethicists about the possibility of using drugs, as well as other technologies, to enhance cognition in healthy individuals. This excitement has arisen from recent advances in neuroscientific technologies such as drugs that increase alertness and wakefulness in healthy individuals or technologies that can stimulate activity in different parts of the brain - either via the scalp or via electrodes - raising the possibility of producing cognitive and affective improvements in otherwise healthy individuals. Despite this growing interest, there are conflicting views on the ethics of cognitive enhancement. Some argue that enhancement is not only an ethical pursuit but one that we have a moral obligation to pursue. Others are more skeptical about the ethical implications and long term effects of cognitive enhancement. Some neuroscientists argue that use of stimulants as putative enhancers will lead to misuse, abuse and addiction in some users, and might have undesirable long-term consequences. This book critically explores and analyses the scientific and ethical debates surrounding cognitive enhancers. Including contributions from neuroscientists, neuropsychopharmacologists, ethicists, philosophers, public health professionals, and policy researchers, the book offers a multidisciplinary, critical consideration of the ethics of the use of cognitive enhancers.

Presents an overview of the cellular and molecular mechanisms underlying the development of cognitive impairment. This book integrates discoveries concerning dementia, such as mild cognitive impairment and Alzheimer's disease associated dementia, retardation syndromes, and psychiatric and neurological disorders related cognitive impairments.